Karnabi Priscilla, Massicotte-Azarniouch David, Ritchie Lindsay J, Marshall Shawn, Knoll Greg A
Clinical Epidemiology Program, The Ottawa Hospital Research Institute, ON, Canada.
Department of Medicine, University of Ottawa, ON, Canada.
Can J Kidney Health Dis. 2023 Jun 22;10:20543581231181026. doi: 10.1177/20543581231181026. eCollection 2023.
With an aging population and growing number of patients with chronic kidney disease (CKD), integrating the latest risk factors when deciding on a treatment plan can result in better patient care. Frailty remains a prevalent syndrome in CKD resulting in adverse health outcomes. However, measures of frailty and functional status remain excluded from clinical decision making.
To examine the degree to which different measures of frailty and functional status are associated with mortality, hospitalization, and other clinical outcomes in patients with advanced CKD.
Systematic review.
Observation studies including cohort study, case-control study, or cross-sectional study examining frailty and functional status on clinical outcomes. There were no restrictions on type of setting or country of origin.
Adults with advanced CKD, including both types of dialysis patients.
Data including demographic information (e.g., sample size, follow-up time, age, country), assessments of frailty or functional status and their domains, and outcomes including mortality, hospitalization, cardiovascular events, kidney function, and composite outcomes were extracted.
A search was conducted using databases Medline, Embase, and Cochrane Central Register for Controlled Trials. Studies were included from inception to March 17, 2021. The eligibility of studies was screened by 2 independent reviewers. Data were presented by instrument and clinical outcome. Point estimates and 95% confidence intervals from the fully adjusted statistical model were reported or calculated from the raw data.
A total of 117 unique instruments were found among 140 studies. The median sample size of studies was 319 (interquartile range, 161-893). Most studies focused on incident and chronic dialysis patient populations, with only 15% of studies examining non-dialysis CKD patients. Frailty and lower functional status were associated with an increased risk for adverse clinical outcomes such as mortality and hospitalization. The 5 individual domains of frailty were also found to be associated with poor health outcomes.
Meta-analysis could not be performed due to significant heterogeneity between studies and methods used to measure frailty and functional status. Many studies had issues with methodological rigor. Selection bias and the validity of data collection could not be ascertained for some studies.
Frailty and functional status measures should be integrated to help guide clinical care decision making for a comprehensive assessment of risk for adverse outcomes among patients with advanced CKD.
CRD42016045251.
随着人口老龄化以及慢性肾脏病(CKD)患者数量的增加,在制定治疗方案时纳入最新的风险因素可带来更好的患者护理。衰弱仍是CKD中一种普遍存在的综合征,会导致不良健康结局。然而,衰弱和功能状态的评估指标仍未被纳入临床决策。
探讨不同的衰弱和功能状态评估指标与晚期CKD患者的死亡率、住院率及其他临床结局之间的关联程度。
系统评价。
观察性研究,包括队列研究、病例对照研究或横断面研究,考察衰弱和功能状态对临床结局的影响。对研究背景类型或原产国没有限制。
晚期CKD成人患者,包括两类透析患者。
提取的数据包括人口统计学信息(如样本量、随访时间、年龄、国家)、衰弱或功能状态及其领域的评估,以及包括死亡率、住院率、心血管事件、肾功能和综合结局在内的结局指标。
使用Medline、Embase和Cochrane对照试验中央注册库数据库进行检索。纳入从数据库建立至2021年3月17日的研究。由2名独立评审员筛选研究的纳入资格。数据按工具和临床结局进行呈现。报告或根据原始数据计算完全调整统计模型的点估计值和95%置信区间。
在140项研究中总共发现了117种独特的工具。研究的样本量中位数为319(四分位间距,161 - 893)。大多数研究聚焦于新发和慢性透析患者群体,只有15%的研究考察非透析CKD患者。衰弱和较低的功能状态与死亡率和住院率等不良临床结局风险增加相关。还发现衰弱的5个个体领域与不良健康结局相关。
由于研究之间以及用于测量衰弱和功能状态的方法存在显著异质性,无法进行荟萃分析。许多研究存在方法学严谨性问题。对于一些研究,无法确定选择偏倚和数据收集的有效性。
应综合考虑衰弱和功能状态指标,以帮助指导临床护理决策,对晚期CKD患者不良结局风险进行全面评估。
PROSPERO注册号:CRD42016045251。